Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (231-240 of 349) with videos related to

Pageof 35
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|March 11, 2021
Pharmacokinetic comparison between tablet of varenicline tartrate and orally disintegrating film of varenicline salicylate in healthy subjectsEunwoo Kim, Jun Gi Hwang, Su Jun Park, et al.
Therapeutic Drug Monitoring|March 23, 2017
A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug MonitoringHyewon Chung, Kyung-Sang Yu, Kyung Taek Hong, et al.
Investigational New Drugs|December 15, 2023
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjectsHyun Chul Kim, Eunsol Yang, Soyoung Lee, et al.
Clinical Pharmacology in Drug Development|December 29, 2023
Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy SubjectsJuyoung Khwarg, Woo Kyung Chung, Soyoung Lee, et al.
Journal of Cardiovascular Pharmacology|September 22, 2011
Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteersHyewon Jeon, Kyoung Soo Lim, Kwang-Hee Shin, et al.
Clinical Drug Investigation|May 8, 2014
Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjectsMin Kyu Park, Tae-Eun Kim, JaeWoo Kim, et al.
Medical Mycology|June 16, 2011
Voriconazole-associated severe hyponatremiaKye-Hyung Kim, Seunghwan Lee, Shinwon Lee, et al.
Clinical and Translational Science|August 16, 2021
The necessary conduct: Exploratory multiregional clinical trials in East AsiaInseung Jeon, Yu Kyong Kim, Ildae Song, et al.
Clinical Therapeutics|December 31, 2013
Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating studyNamyi Gu, Sang-Heon Cho, Jaewoo Kim, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2011
Effect of age on the pharmacokinetics of fimasartan (BR-A-657)Hae Won Lee, Mi-Sun Lim, Sook Jin Seong, et al.
Pageof 35

Showing results (231-240 of 349) with videos related to

Sort By:
Pageof 35
International Journal of Clinical Pharmacology and Therapeutics|March 11, 2021
Pharmacokinetic comparison between tablet of varenicline tartrate and orally disintegrating film of varenicline salicylate in healthy subjectsEunwoo Kim, Jun Gi Hwang, Su Jun Park, et al.
Therapeutic Drug Monitoring|March 23, 2017
A Significant Influence of Metronidazole on Busulfan Pharmacokinetics: A Case Report of Therapeutic Drug MonitoringHyewon Chung, Kyung-Sang Yu, Kyung Taek Hong, et al.
Investigational New Drugs|December 15, 2023
Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjectsHyun Chul Kim, Eunsol Yang, Soyoung Lee, et al.
Clinical Pharmacology in Drug Development|December 29, 2023
Evaluation of Food Effect on the Pharmacokinetics of Velufenacin, a New Muscarinic Receptor Antagonist, in Healthy SubjectsJuyoung Khwarg, Woo Kyung Chung, Soyoung Lee, et al.
Journal of Cardiovascular Pharmacology|September 22, 2011
Assessment of the drug-drug interactions between fimasartan and hydrochlorothiazide in healthy volunteersHyewon Jeon, Kyoung Soo Lim, Kwang-Hee Shin, et al.
Clinical Drug Investigation|May 8, 2014
Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjectsMin Kyu Park, Tae-Eun Kim, JaeWoo Kim, et al.
Medical Mycology|June 16, 2011
Voriconazole-associated severe hyponatremiaKye-Hyung Kim, Seunghwan Lee, Shinwon Lee, et al.
Clinical and Translational Science|August 16, 2021
The necessary conduct: Exploratory multiregional clinical trials in East AsiaInseung Jeon, Yu Kyong Kim, Ildae Song, et al.
Clinical Therapeutics|December 31, 2013
Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating studyNamyi Gu, Sang-Heon Cho, Jaewoo Kim, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 29, 2011
Effect of age on the pharmacokinetics of fimasartan (BR-A-657)Hae Won Lee, Mi-Sun Lim, Sook Jin Seong, et al.
Pageof 35